Navidea Biopharmaceuticals, Inc. (NAVB) .
이 페이지에서 입증된 기준:
SharesGrow 종합 점수: 23/100 1/7 개 기준 통과.
| Year | EPS (희석) | 매출 | 순이익 | 순이익률 |
|---|---|---|---|---|
| 2013 | $-7.01 | $1.13M | $-42.7M | -3776.6% |
| 2014 | $-4.80 | $6.27M | $-35.73M | -569.4% |
| 2015 | $-3.65 | $13.25M | $-27.56M | -208% |
| 2016 | $-1.84 | $21.97M | $-14.31M | -65.1% |
| 2017 | $9.00 | $1.81M | $74.95M | 4139.7% |
| 2018 | $-1.89 | $322.52K | $-16.13M | -5000.1% |
| 2019 | $-0.76 | $26.62K | $-10.95M | -41120.9% |
| 2020 | $-0.45 | $915.01K | $-10.64M | -1162.8% |
| 2021 | $-0.40 | $531.51K | $-11.73M | -2207.1% |
| 2022 | $-0.56 | $65.65K | $-15.18M | -23117.6% |
